IRAK3 and Sepsis: At ST (1h) following ex vivo challenge with LPS, IRAK3 mRNA expression in samples of patients with sepsis further increases compared to unchallenged samples and healthy subjects, and this corresponds to two-challenge animal in vivo models (Fig 5) [35].